Cellebrite DI (CLBT) Receivables - Other (2020 - 2025)

Cellebrite DI's Receivables - Other history runs 6 years deep, the most recent figure standing at $78.6 million for Q4 2025.

• In Q4 2025, Receivables - Other fell 3.41% year-over-year to $78.6 million; the TTM figure through Dec 2025 stood at $78.6 million (down 3.41% YoY), while the FY2025 annual figure was $78.6 million, down 3.41% from the prior year.
• Receivables - Other was $78.6 million for Q4 2025 at Cellebrite DI, down from $81.3 million in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $89.2 million in Q4 2023 to a low of $72.3 million in Q4 2021.
• Historically, Receivables - Other has averaged $80.6 million across 5 years, with a median of $81.3 million in 2024.
• The sharpest annual moves came in 2021 and 2024: Receivables - Other soared 113.13% in 2021, then decreased 8.78% in 2024.
• A 5-year view of Receivables - Other shows it stood at $72.3 million in 2021, then grew by 12.83% to $81.5 million in 2022, then advanced by 9.38% to $89.2 million in 2023, then retreated by 8.78% to $81.3 million in 2024, then dropped by 3.41% to $78.6 million in 2025.
• The last three Receivables - Other figures came in at $78.6 million (Q4 2025), $81.3 million (Q4 2024), and $89.2 million (Q4 2023), per Business Quant data.